Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.
Recipharm will invest EUR 32 million ($43 million) in its Wasserburg, Germany site located near Munich to create a new building that will house a fourth production area adding to the three already in operation. This development will increase the company’s lyophilization capacity and automatic loading and unloading technology. The building will also have the flexibility to accommodate further production lines. The number of employees will be increased from the current 282 to 320, and the new area is expected to be operational in 2016.
Source: Recipharm
PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations
January 8th 2025The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.